Monopar Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update
- Tech Inc reported fourth quarter and full year 2025 financial results, with revenue of $7.51M beating expectations by $235.31K. The company posted an EPS of-$0.01.
- As an AI-enabled InsurTech platform, the company operates a marketplace improving health insurance industry processes through vertical integration and automation. It serves brokers, Managing General Underwriter , and third-party administrators .
- CEO Tim Johnson and CFO Julia Qian led the Earnings Conference Call to discuss results. Full details appear in the Form 10-K filed with the SEC, available on the Investor Relations website.
- Streamlining underwriting, sales, and service processes remains a core operational focus for the firm. By removing friction, it improves efficiency for insurance companies, brokers, MGUs, and TPAs.
- Projections made pursuant to the Private Securities Litigation Reform Act of 1995 reflect current views on potential operational results. Management cautioned that forward-looking statements regarding growth strategies involve known and unknown risks and uncertainties.
41 Articles
41 Articles
Monopar Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update
WILMETTE, Ill., March 27, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar,” the “Company,” “we”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today announced the fourth quarter and full-year 2025 financial results…
iAnthus Reports Fiscal Fourth Quarter and Full Year 2025 Financial Results
NEW YORK and TORONTO, March 27, 2026 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”) (CSE: IAN, OTCID: ITHUF), which owns, operates, and partners with regulated cannabis operations across the United States, today reported its financial results…
Coverage Details
Bias Distribution
- 55% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium

















